StockClub

VRTX

VRTXVertex Pharmaceuticals Incorporated$ --
Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Incorporated

VRTX

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
3,227M USD
YoY +10.8%
Operating Income
1,300M USD
YoY +26.7%
Net Income
1,191M USD
YoY +30.5%
EPS
4.69$
YoY +32.1%

Revenue

$12B
FY2024 Q1$2.7B
$2.7B
Q1
FY2024 Q2$5.3B
$5.3B
Q2
FY2024 Q3$8.1B
$8.1B
Q3
FY2024 Q4$11B
$11B
Q4
FY2025 Q1$2.8B
$2.8B
Q1
FY2025 Q2$5.7B
$5.7B
Q2
FY2025 Q3$8.8B
$8.8B
Q3
FY2025 Q4$12B
$12B
Q4
Actual
+$1B (+9.3%)

Net Income

$4B
FY2024 Q1$1.1B
$1.1B
Q1
FY2024 Q2$-2.5B
$-2.5B
Q2
FY2024 Q3$-1.4B
$-1.4B
Q3
FY2024 Q4$-535.6M
$-535.6M
Q4
FY2025 Q1$646.3M
$646.3M
Q1
FY2025 Q2$1.7B
$1.7B
Q2
FY2025 Q3$2.8B
$2.8B
Q3
FY2025 Q4$4B
$4B
Q4
Actual
+$4.5B (+838.1%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020BEAT
Actual:$6.2B
Est:$6.2B
FY2020BEAT
$6.2B
FY2021BEAT
Actual:$7.6B
Est:$7.5B
FY2021BEAT
$7.6B
FY2022MISS
Actual:$8.9B
Est:$8.9B
FY2022MISS
$8.9B
FY2023MISS
Actual:$9.9B
Est:$10.3B
FY2023MISS
$9.9B
FY2024BEAT
Actual:$11B
Est:$10.9B
FY2024BEAT
$11B
FY2025BEAT
Actual:$12.1B
Est:$12B
FY2025BEAT
$12.1B

Analyst Estimates